Previous Close | 0.4800 |
Open | 0.5000 |
Bid | 0.4800 x N/A |
Ask | 0.4950 x N/A |
Day's Range | 0.4800 - 0.5000 |
52 Week Range | 0.2250 - 0.6700 |
Volume | |
Avg. Volume | 32,164 |
Market Cap | 26.647M |
Beta (5Y Monthly) | 0.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | May 27, 2024 - May 31, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.10 |
MONTRÉAL, April 08, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Health tech company, announces the appointment of Bruno Morel as the Corporation’s new Chief Technology Officer, effective immediately. “We are very excited to have Bruno join Premier Health. His hiring follows our recent Canadian expansion and is one of the key catalysts of our technology roadmap. He will be an important member of the Corporation’s
MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended on December 31st, 2023. Highlights (in thousands of Canadian dollars)Dec. 31, 2023(3 months)Dec. 31, 2022(3 months)Revenues36,973 21,576 Gross margin7,657 5,064 Gross margin as a % of revenues20.7%23.5%Adjusted EBITDA (1)2,622 1,504 Ne
MONTRÉAL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its financial year ended September 30, 2023. 2023 Highlights (in thousands of Canadian dollars)Sept 30, 2023(3 months)Sept 30, 2022(3 months)Sept 30, 2023(12 months)Sept 30, 2022(12 months)Revenues23,405 22,087 90,390 80,507 Gross margin6,036 5,851 23,345 20,